Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Noradrenaline in basic models of depression

B E Leonard1

  • 1Department of Pharmacology, University College, Galway, Ireland.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|April 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SSRI differentiation: Pharmacology and pharmacokinetics.

Human psychopharmacology·2018
Same author

The effects of castration and hormone replacement on runway behaviour and GABA concentrations in the septum.

Irish journal of medical science·2016
Same author

Immune dysfunction, depression and neurodegeneration.

Acta neuropsychiatrica·2014
Same author

Some behavioural and neurochemical effects of ipsapirone in two rodent models of depression.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Effects of chronic desipramine on waiting behaviour for a food reward in olfactory bulbectomized rats.

Journal of psychopharmacology (Oxford, England)·2012
Same author

The effects of chronic lithium chloride administration on some behavioural and immunological changes in the bilaterally olfactory bulbectomized rat.

Journal of psychopharmacology (Oxford, England)·2012
Same journal

Commentary on: The American Society of Clinical Psychopharmacology task force consensus statement on the deprescribing of stimulant medications in adults with ADHD.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Corrigendum to "Functioning assessment short test for autism (FAST-A): a tool to evaluate adaptive functioning in autistic adults" [European Neuropsychopharmacology, 112, 112887].

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genomic relationship between polyendocrine metabolic ovarian syndrome and bipolar disorder.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Genetic overlap between depression and C-reactive protein levels: Evidence from a cross-trait analysis.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

Variability in AI-generated psychedelic definitions across major chatbots.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
Same journal

In-patient treatment and structural dysconnectivity in major depression - A longitudinal connectome study.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2026
See all related articles

Depression may involve noradrenergic system abnormalities. Reboxetine, a selective noradrenaline-reuptake inhibitor (NARI), shows antidepressant effects in animal models, suggesting a targeted treatment approach.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Psychiatry

Background:

  • Depression is linked to noradrenergic system dysfunction.
  • Existing animal models for depression show varied noradrenergic changes.
  • Alpha-2 and beta-adrenoceptors are implicated in depression.

Purpose of the Study:

  • To evaluate reboxetine, a selective noradrenaline-reuptake inhibitor (NARI).
  • To assess reboxetine's antidepressant efficacy in olfactory bulbectomised rats.
  • To determine reboxetine's selectivity for the noradrenergic system.

Main Methods:

  • Anatomical studies of alpha-2 and beta-adrenoceptors.
  • Olfactory bulbectomy in rats to induce amygdala changes.
  • Assessment of reboxetine in forced swim and open field tests.

Related Experiment Videos

  • Testing reboxetine's effect in the 8-OH-DPAT hypothermia test.

    • Main Results:

    • Reboxetine demonstrated antidepressant activity in bulbectomised rats.
    • Reboxetine was ineffective in the 8-OH-DPAT hypothermia test.
    • These findings indicate reboxetine's selectivity for the noradrenergic system.

    Conclusions:

    • Noradrenergic system abnormalities are evident in depression.
    • Targeting the noradrenergic system is a rational therapeutic strategy.
    • Selective noradrenaline-reuptake inhibitors like reboxetine warrant further investigation for depression treatment.